Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome): update of August 28, 2026

A genetic test confirmed a patient had a rare syndrome related to hereditary hemorrhagic telangiectasia, helping to re-evaluate family members’ prior diagnoses.

This new study aims to assess how well a drug called engasertib may reduce nosebleeds in patients with moderate to severe hereditary hemorrhagic telangiectasia.

A study will explore the safety and effects of the drug ALN-6400 in both healthy individuals and those with hereditary hemorrhagic telangiectasia.

This study is testing the safety and effectiveness of ATV-1601 on patients with moderate to severe hereditary hemorrhagic telangiectasia.

A review found some topical treatments may help with nosebleeds in hereditary hemorrhagic telangiectasia, although results varied across studies.

Research suggests hereditary hemorrhagic telangiectasia may be more common than thought, impacting how it is diagnosed and managed.

A case highlights that a patient with unusual symptoms was diagnosed with hereditary hemorrhagic telangiectasia, stressing the need to consider atypical signs.

This review discusses how inflammation may drive the development and complications of brain arteriovenous malformations.

This research identified new genetic changes in families with hereditary hemorrhagic telangiectasia type 1, linked to varying symptoms and conditions.

A treatment method using ammonia sampling showed promise in improving symptoms of severe liver complications in hereditary hemorrhagic telangiectasia patients.

A review is examining current evidence on treatments for hereditary hemorrhagic telangiectasia and exploring new potential therapies.

A study will evaluate how safe and effective a topical treatment is for managing nosebleeds in patients with hereditary hemorrhagic telangiectasia.

This pediatric case study highlights a child's diagnosis of a rare syndrome linked to anemia and pulmonary issues.

This analysis aims to examine the effectiveness of a drug for treating hereditary hemorrhagic telangiectasia in French patients.

Research indicates hereditary hemorrhagic telangiectasia is often underdiagnosed and identifies important genetic markers for better management.

A case report describes a young man whose fainting spells were related to a rare lung condition linked to hereditary hemorrhagic telangiectasia.

A patient with severe gastrointestinal bleeding found relief through specific treatments for hereditary hemorrhagic telangiectasia.

A new registry is being established to improve the understanding and treatment of hereditary hemorrhagic telangiectasia.

This study will explore the best dose of an intranasal treatment for nosebleeds in patients with hereditary hemorrhagic telangiectasia.

A study analyzed immune cells in brain arteriovenous malformations, showing a link to new treatment strategies.

A study looked at how well doxycycline might reduce nosebleeds in people with hereditary hemorrhagic telangiectasia, analyzing responses based on their genetic types.